Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D)

Clinical trial NCT02879305 · COMPLETED

Trial details

NCT number: NCT02879305
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Anaemia Aspergillosis, Allergic Bronchopulmonary

Start date: 2016-09-28
Primary completion: 2020-11-09
Enrollment: 2964

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.